Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsCreative Biolabs makes a breakthrough in guinea pig monoclonal antibody production service via hybridoma technology. Contrary to the disappointing rabbit hybridoma technology which has generally indicated low stability and productivity, our cutting-edge guinea pig hybridoma technique exploits a novel source of outbreeding non-murine immune repertoire with stable productivity.
The word "guinea pig" is synonymous with scientific experiments, and this animal model has been in use for about 200 years and was the first to be used to study infectious diseases such as tuberculosis and diphtheria, but much less is known about this species than many other laboratory animals. Guinea pig, as a representative model of tuberculosis, is considered the "gold standard" for preclinical studies of new drugs and vaccines, various administration methods, and safety evaluation. Guinea pig is an ideal source to generate antibodies for extreme allergic reactions or anaphylaxis research, and also be treated as an important model for the study of various infectious diseases, such as tuberculosis and diphtheria.
Fig.1 Workflow for the production of monoclonal antibodies using guinea pigs.
Features of Our Service
|
Order Process
We keep the ordering procedure as easy as possible. Please submit the following information to assist us in correlating your antigen with your order and accelerate the process:
|
According to these properties, guinea pigs are considered with huge potential to generate novel target-specific monoclonal antibodies for a series of research and therapeutic studies.
As a well-recognized expert in antibody research, Creative Biolabs can proudly offer the unique guinea pig hybridoma technology to generate monoclonal guinea pig antibodies. Through fusing with our specific myeloma as a partner, guinea pig hybridoma can be developed with excellent stability and productivity. Our scientists are confident in developing guinea pig hybridoma that produces monoclonal antibodies with high affinity and specificity.
If you have any questions, please feel free to contact us, we welcome to discuss the project solutions with you further.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
